I recently had the pleasure to spend time with the team at Applied Clinical Trials. Following our discussion they published an interview in the September edition of Applied Clinical Trials Magazine.
The interview is titled “Workforce Readiness Technology Minimizes Risk in Clinical Trials” and it explores how ArcheMedX is enabling Sponsors, CROs, and other trial stakeholders to improve clinical trial readiness.
Here’s the introduction and the full interview can be found below. Enjoy!
“Clinical trials often encounter operational challenges and sponsors and CROs seek effective site-readiness practices. In this interview, Joel B. Selzer, co-founder and CEO, ArcheMedX, Inc., discusses the impact that healthcare technology has on clinical trials, focusing on the development of the company’s workforce readiness platform.”
Related Post
Breaking the Cycle of Ineffective Site Initiation Practices
As the SCOPE Summit approaches next week, it's clear sponsors and CROs still face many…
ArcheMedX Team
How ‘Slow Thinking’ Enables Clinical Research Teams to Work Faster
How can we combat the sense of urgency our professional lives bring? We are each burdened…
Brian S McGowan, PhD
ArcheMedX To Present at Innovation Showcase and Poster Sessions during the 2023 CNS Summit
Analyses of 95,724 clinician learners across 91 CNS-related educational activities, including rater-related scales and assessments,…
